医薬品・バイオテクノロジーにおける製造・供給取引：2020年～2025年

医薬品とバイオテクノロジーにおける製造・供給取引は、企業が製造・供給取引に参入する方法と理由について詳細な理解と分析を提供します。全面的に改訂・更新された当レポートは、2019年から2025年までの製造・供給取引の詳細を提供しています。

当レポートは、当事者間で発表された製造・供給取引の支払条件へのアクセスを提供します。このデータは、支払い条件やその他の取引条件に関する有用な洞察を提供します。

パートナー候補の交渉済み取引条件の柔軟性を理解することで、条件交渉中に何を期待できるかという点で、交渉プロセスに対する重要な洞察が得られます。多くの中小企業は支払い条項の詳細を求めるとみられますが、支払いがどのように開始され、権利がどのように移転されるかという点では、悪魔は細部に宿るものです。

当レポートでは、2020年以降に発表された製造・供給取引について、Current Agreementsの取引・提携データベースに記録されている包括的なリストと、入手可能な場合は財務条件も含め、さらに企業やそのパートナーが証券取引委員会に提出した実際の製造・供給取引文書のオンライン・コピーへのリンクを掲載しています。

当レポートの最初の章では、製造・供給取引と事業活動の方向性を示しています。

第1章では、当レポートのイントロダクションを提供し、第2章では、製造・供給の動向の概要と分析、および取引タイプのメリットに関する議論を提供します。

第3章では、製造・供給取引の構造を概観しています。

第4章では、2020年以降の主要な製造・供給案件のレビューを行います。案件は金額別にリストアップされています。SECで公表された契約書がある案件については、リンクからCurrent AgreementsのDeal & Alliance データベースを通じて契約書にオンラインでアクセスすることができます。

第5章では、最も活発な製造・供給取引メーカー上位25社の包括的なリストを提供しています。各取引タイトルは、Current AgreementsのDeal & Alliance データベースを通じて、取引レコード全文のオンラインバージョンにリンクしており、利用可能な場合には実際の契約文書にもリンクしているため、各取引レコードにオンデマンドで簡単にアクセスすることができます。

第6章では、契約文書が入手可能な場合、2020年以降に締結・発表された製造・供給取引の包括的かつ詳細なレビューを、企業A-Z、治療法、技術、業種別に整理しています。契約文書では、製造・供給取引に関して当事者間で合意された実際の取引条件について、詳細な洞察が得られます。

取引ディレクトリーには、2019年以降に発表されたすべての製造・供給取引の包括的なリストが含まれています。各リストは、企業A-Z、治療分野、技術タイプ別に取引ディレクトリーとして構成されています。各取引タイトルは、ハイパーリンクを介して、利用可能な場合には実際の契約文書を含む取引レコードのオンライン版にリンクしています。

また当レポートには、2020年以降の製造・供給取引の動向や活動を示す図表も多数掲載されています。

目次

エグゼクティブサマリー

第1章 イントロダクション

第2章 製造業とサプライチェーンの動向

• イントロダクション
• 製造・供給取引の定義
• 2020年以降の製造・供給取引の動向
  • 製造・供給取引の年別推移、2020年～2025年
  • 開発段階別の製造・供給取引、2020年～2025年
  • 産業セクター別の製造・供給取引、2020年～2025年
  • 治療領域別の製造・供給取引、2020年～2025年
  • 技術タイプ別の製造・供給取引、2020年～2025年
  • 最も活発な企業別製造・供給取引、2020年～2025年
• 製造・供給提携契約を締結する理由
• 製造と供給取引の未来

第3章 製造・供給取引構造の概要

• イントロダクション
• 製造および供給取引の構造

第4章 主要な製造・供給取引

• イントロダクション
• 金額別トップ製造・供給取引

第5章 最も活発な製造・供給取引メーカー上位25社

• イントロダクション
• 最も活発な製造・供給取引メーカー上位25社

第6章 契約ディレクトリを含む製造・供給取引

• イントロダクション
• 2020年～2025年の取引別の製造・供給取引
• 取引ディレクトリ
• 取引ディレクトリ- 企業別の製造・供給取引（AZ）
• 取引ディレクトリ- 治療領域別の製造・供給取引
• 取引ディレクトリ- 技術タイプ別の製造・供給取引
• 調査会社について
• 現在の提携
• 現在の契約
• Current Partneringからの最近のレポートタイトル

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter manufacturing and supply deals.

Fully revised and updated, the report provides details of manufacturing and supply deals from 2019 to 2025.

The report provides access to manufacturing and supply deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of manufacturing and supply deals announced since 2020 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual manufacturing and supply contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of manufacturing and supply dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in manufacturing and supply as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of manufacturing and supply deals.

Chapter 4 provides a review of the leading manufacturing and supply deals since 2020. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active manufacturing and supply dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of manufacturing and supply deals organized by company A-Z, therapy, technology and industry type signed and announced since 2020 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the manufacturing and supply deal.

The deal directory includes a comprehensive listing of all manufacturing and supply deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in manufacturing and supply dealmaking since 2020.

In conclusion, this report provides everything a prospective dealmaker needs to know about manufacturing and supply alliances.

Key benefits

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2020
• Browse manufacturing and supply deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the manufacturing and supply trends and structure of deals entered into by leading biopharma companies worldwide.

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology includes:

• Trends in manufacturing and supply dealmaking in the biopharma industry
• Overview of manufacturing and supply deal structure
• Directory of manufacturing and supply deal records covering pharmaceutical and biotechnology
• The leading manufacturing and supply deals by value
• Most active manufacturing and supply dealmakers
• The leading manufacturing and supply partnering resources

In Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for manufacturing and supply deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in manufacturing and supply dealmaking

• 2.1. Introduction
• 2.2. Definition of manufacturing and supply deal
• 2.3. Trends in manufacturing and supply deals since 2020
  • 2.3.1. Manufacturing and supply dealmaking by year, 2020-2025
  • 2.3.2. manufacturing and supply dealmaking by phase of development, 2020-2025
  • 2.3.3. Manufacturing and supply dealmaking by industry sector, 2020-2025
  • 2.3.4. Manufacturing and supply dealmaking by therapy area, 2020-2025
  • 2.3.5. Manufacturing and supply dealmaking by technology type, 2020-2025
  • 2.3.6. Manufacturing and supply dealmaking by most active company, 2020-2025
• 2.4. Reasons for entering into manufacturing and supply partnering deals
• 2.5. The future of manufacturing and supply deals

Chapter 3 - Overview of manufacturing and supply deal structure

• 3.1. Introduction
• 3.2. manufacturing and supply agreement structure

Chapter 4 - Leading manufacturing and supply deals

• 4.1. Introduction
• 4.2. Top manufacturing and supply deals by value

Chapter 5 - Top 25 most active manufacturing and supply dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active manufacturing and supply dealmakers

Chapter 6 - manufacturing and supply deals including contracts directory

• 6.1. Introduction
• 6.2. manufacturing and supply deals with contracts 2020-2025
• Deal directory
• Deal directory - manufacturing and supply dealmaking by companies A-Z
• Deal directory - manufacturing and supply dealmaking by therapy area
• Deal directory - manufacturing and supply dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of manufacturing and supply
• Figure 2: Trends in manufacturing and supply deal announcements, 2020-2025
• Figure 3: Manufacturing and supply deals signed at each phase of development, 2020-2025
• Figure 4: Manufacturing and supply deals by industry sector, 2020-2025
• Figure 5: Manufacturing and supply deals by therapy area, 2020-2025
• Figure 6: Manufacturing and supply deals by technology type, 2020-2025
• Figure 7: Top 25 most active manufacturing and supply dealmakers, 2020-2025
• Figure 8: Top manufacturing and supply deals by value, 2020-2025
• Figure 9: Most active manufacturing and supply dealmakers, 2020-2025